The Cleveland Plain Dealer reported that the FDA “recently told the makers of Singulair and three less widely used asthma drugs — Accolate, Zyflo and Zyflo CR — that the drugs’ labels must list a dozen mood and behavior changes as possible side effects.” The article focuses on a group of mothers who had pushed for the warning. “The group’s goal now is to get a ‘black box’ warning for Singulair.”
From the American Association for Justice news release.
http://www.pissd.com/2009/06/mothers-push-for-singulair-black-box-warning/trackback/
I am a Dallas, Texas lawyer who has had the privilege of helping thousands of clients since 1971 in the areas of Personal Injury law, Social Security Disability, Immigration, Bankruptcy, & Consumer Protection.
Please click the CONTACT button at the top of this page if you have questions about Personal Injury, Social Security Disability, Immigration, Bankruptcy, or Consumer Law. You’ll find we’re easy to talk to, and we never charge for that first phone call.
I am a mother who has lost her daughter to this medication. My daughter completed suicide after three horrible years on this medication. I am so grateful that the word is finally getting out so that other children do not have to suffer. Nothing will give me back my beautiful daughter, but saving other parents from this suffering does bring me some peace. The FDA MUST protect our children!
I am the mother of the boy featured in the story,i cannot express to you enough how awful the effects of this drug are,and yet i feel as though i was one of the lucky ones,my child is still here and recovering,while way to many are not.The process of getting this warning was way to hard,who knew protecting children would be a full time job.I do question as to why they finished their investigation in April,but did not release it till June,when allergy season was about over,a short time before the stock market closed,on a busy news friday afternoon,when Iran was holding its elections,i think we all knew that would be a huge story.
Thank you for sharing your story with us. I hope you will use this experience to continue to crusade for tighter drug regulation.